Research notes.
A quarterly reading list on peptide pharmacology, compound purity, storage, and what published research actually says. Written for researchers who read primary literature.
Peptide Therapy Canada: Longevity Research 2026
Peptide therapy in Canada: a survey of 2024–2026 longevity research — what studies moved the field, where evidence is strongest & what stays speculative.
Read the dispatch →Peptide Therapy Canada: Longevity Research 2026
Peptide therapy in Canada: a survey of 2024–2026 longevity research — what studies moved the field, where evidence is strongest & what stays speculative.
Lyophilized vs Pre-Mixed Peptides: Format Guide
Lyophilized vs pre-mixed peptides format guide: why sourcing is moving toward lyophilized powder — stability, purity verification and shelf life compared.
Semaglutide to Retatrutide Peptide Shift (Canada)
The semaglutide-to-retatrutide peptide shift in Canada: triple-agonist peptides beyond semaglutide & tirzepatide. Research timeline & open questions.
Epithalon: What the Recent Telomerase Studies Actually Found
A plain-English reading of the 2022–2025 Epithalon studies — what was measured, what was claimed, and what the effect sizes look like in context.
BPC-157 Peptide: 2026 Animal-Model Data
BPC-157 peptide 2026 data review: recent animal-model studies on tendon repair, gut permeability & neurological injury — what the evidence shows now.